Pharma

Your Article Summary

See Latest Articles

Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
Amylin Pharmaceuticals, 10/20/09

Amylin Pharmaceuticals, Inc. announced that new data from its obesity program will be presented at Obesity 2009, the 27th Annual Scientific Meeting of The Obesity Society, to be held in Washington, D.C. October. Phase 2 data from the pramlintide/metreleptin combination treatment clinical program will be the subject of a late–breaking oral presentation. Obesity 2009 is one of the largest scientific conferences in the field of obesity.

Today in Conferences/Meetings...keeping you current

Receive free subspecialty "5-minute updates" via email

Quality of trials reported as conference abstracts in China: How well are they reported
International Journal of Technology Assessment in Health Care, 11/05/09

User Groups Prove Helpful
HealthDataManagement, 11/03/09

Salix Pharmaceuticals Reviews American Association For The Study Of Liver Diseases Annual Meeting
Salix Pharmaceuticals, 11/03/09

See All of Conferences/Meetings